Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / HEALTHCARE BUL
-
Total 13F shares
-
119,630
-
Share change
-
-42,585
-
Total reported value
-
$12,749,419
-
Put/Call ratio
-
57%
-
Price per share
-
$106.61
-
Number of holders
-
21
-
Value change
-
-$3,651,625
-
Number of buys
-
11
-
Number of sells
-
14
Institutional Holders of DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) as of Q1 2025
As of 31 Mar 2025,
DIREXION SHS ETF TR - HEALTHCARE BUL (CURE) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
119,630 shares.
The largest 10 holders included
GTS SECURITIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, Bullseye Investment Management, LLC, Traynor Capital Management, Inc., CITADEL ADVISORS LLC, SBI Securities Co., Ltd., UBS Group AG, JANE STREET GROUP, LLC, Belvedere Trading LLC, and Tower Research Capital LLC (TRC).
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.